|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0014025,
umls-concept:C0018801,
umls-concept:C0027100,
umls-concept:C0126174,
umls-concept:C0162521,
umls-concept:C0184511,
umls-concept:C0242692,
umls-concept:C0392747,
umls-concept:C0443172,
umls-concept:C0486616,
umls-concept:C1707520
|
|
pubmed:issue |
17
|
|
pubmed:dateCreated |
1998-11-12
|
|
pubmed:abstractText |
In congestive heart failure, fatigue-resistant, oxidative, slow type I fibers are decreased in leg skeletal muscle, contributing to exercise capacity (EC) limitation. The mechanisms by which ACE inhibitors and AII antagonists improve EC is still unclear. We tested the hypothesis that improvement in EC is related to changes in skeletal muscle composition toward type I fibers.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0009-7322
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
27
|
|
pubmed:volume |
98
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1742-9
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9788828-Angiotensin II,
pubmed-meshheading:9788828-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:9788828-Antihypertensive Agents,
pubmed-meshheading:9788828-Enalapril,
pubmed-meshheading:9788828-Exercise Tolerance,
pubmed-meshheading:9788828-Heart Failure,
pubmed-meshheading:9788828-Humans,
pubmed-meshheading:9788828-Losartan,
pubmed-meshheading:9788828-Male,
pubmed-meshheading:9788828-Middle Aged,
pubmed-meshheading:9788828-Muscle, Skeletal,
pubmed-meshheading:9788828-Myosin Heavy Chains
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Improved exercise tolerance after losartan and enalapril in heart failure: correlation with changes in skeletal muscle myosin heavy chain composition.
|
|
pubmed:affiliation |
First Department of Internal Medicine, Venice City Hospital, Venice, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|
